New therapies for coronary artery disease: genetics provides a blueprint.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24898745.
- Also identified by DOI 10.1126/scitranslmed.3008535.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of new therapies for coronary artery disease (CAD) poses a substantial challenge, and several recent approaches have failed for lack of efficacy. Human genetics has the potential to identify new targets for which the likelihood of therapeutic success is considerably greater. The intense focus on the genetics of CAD will revitalize the field and lead to future therapies for this common disease.
Medical subject headings
- Coronary Artery Disease